This guide explains the reactions reported in clinical research, including nausea, diarrhea, vomiting, constipation, fatigue, appetite changes, and injection-site discomfort
In this capacity, semaglutide has shown reliability as a long-term weight-loss therapeutic [3, 5]
While some research suggests that raising growth hormone levels can lead to modest changes in body compositionsuch as reduced fat massthese effects are most pronounced in individuals diagnosed with adult growth hormone deficiency
Paul Morer, 56, who works for a New Jersey hospital system, lost 85 pounds using Wegovy and hopes to lose 30 more
LEADER [29] and SUSTAIN-6 [30] reported a prespecified renal composite of new onset or persistent macroalbuminuria, persistent doubling of serum creatinine and eGFR 45 mL/min/1.73 m 2 , need for renal replacement therapy (RRT), and renal death